Search

Current guidelines for prolonged altitude exposure suggest altitude levels ranging from 2000 to 2500 m to optimize an increase in total hemoglobin mass (Hbmass). However, natural low altitude locations (<2000 m) remain popular, highlighting the interest to investigate any possible benefit of low altitude camps for endurance athletes. Ten elite racewalkers (4 women and 6 men) underwent a 4‐week "live high‐train high" (LHTH) camp at an altitude of 1720 m (PIO2 = 121 mmHg; 20.1°C; 67% relative humidity [RH]), followed by a 3‐week tapering phase (20 m; PIO2 = 150 mmHg; 28.3°C; 53% RH) in preparation for the World Athletics Championships (WC). Venous blood samples were withdrawn weekly during the entire observation period. In addition, blood volumes were determined weekly by carbon monoxide rebreathing during altitude exposure and 2 weeks after return to sea level. High‐level performances were achieved at the WC (five placings among the Top 10 WC races and three all‐time career personal bests). A slight but significant increase in absolute (+1.7%, p = 0.03) and relative Hbmass (+2.3%, p = 0.02) was observed after 4‐week LHTH. In addition, as usually observed during LHTH protocols, weekly training distance (+28%, p = 0.02) and duration (+30%, p = 0.04) significantly increased during altitude compared to the pre‐LHTH period. Therefore, although direct causation cannot be inferred, these results suggest that the combination of increased training load at low altitudes with a subsequent tapering period in a warm environment is a suitable competition‐preparation strategy for elite endurance athletes. Highlights: Despite current guidelines for prolonged altitude exposure, natural low altitude locations (<2000 m) remain popular among elite endurance athletes, highlighting the interest to investigate any possible benefit of low altitude camps.This study reports that elite racewalkers achieved a modest but significant increase in Hbmass after a 4‐week LHTH camp at an altitude of 1720 m. Furthermore, this intervention led to performance success at the subsequent World Athletics Championships.The combination of an increased training load while exposed to low altitude is suggested as a valuable competition preparation strategy for elite endurance athletes. [ABSTRACT FROM AUTHOR]

Background: Current research relates jaw clenching to athletic performance, in terms of force and agility. However, the impact of jaw clenching on sports accuracy is unclear., Objectives: To analyse the impact of jaw position and chewing type on free-throw accuracy and electromyographic (EMG) activity of masticatory muscles during free-throws., Methods: Cross-sectional study with 25 female basketball players aged 18-44. Each participant executed 18 free-throws under three different jaw conditions: mandibular rest, maximum intercuspation, and with interdental cotton rolls, in randomised order., Results: Chewing type and jaw position were not associated with shooting accuracy (p = 0.106; p = 0.778). There was a positive correlation between EMG activity of the right masseter and free-throw accuracy at maximum intercuspation (r s  = 0.402; p = 0.046). In contrast, negative correlations were found with other muscles when the occlusal vertical dimension was altered (r s  = -0.619, p = 0.001; r s  = -0.490; p = 0.013; r s  = -0.534; p = 0.006). The chewing type affected the EMG of the left masseter in the altered occlusal vertical dimension (H = 6.969; p = 0.031). Significant differences in EMG recordings were observed across different mandibular positions during free-throws (p < 0.001)., Conclusions: While jaw positioning and chewing type do not impact free-throw accuracy in amateur female basketball players, the EMG activity of masticatory muscles is linked to shooting performance. This highlights the need for further research on motor behaviour of masticatory muscles in precision sports, especially for athletes using intraoral devices., (© 2024 The Author(s). Journal of Oral Rehabilitation published by John Wiley & Sons Ltd.)

Skin-conformal organic electrochemical transistors (OECTs) have attracted significant attention for real-time physiological signal monitoring and are vital for health diagnostics and treatments. However, mechanical harmonization amid the inherent dynamic nature of the skin surface and the acquisition of intrinsic physiological signals are significant challenges that hinder the integration of the ultimate skin interface. Thus, this study proposes a novel 4-terminal (4-T) vertical Corbino OECT, exhibiting high transconductance (>400 mS) and offering remarkable resilience and operational stability at an extremely low voltage of 10 mV (1.9% of minimal current change after 10 4 biasing cycles and endurance up to 10 3 cycles of repetitive deformation with a 5 µm bending radius). Consequently, ultralow-power, motion-resistant epidermal electrocardiogram, electromyogram, and electrooculogram sensors are developed with an exceptional signal-to-noise ratio of 40.1 dB. The results of this study present a significant stride in non-invasive, skin-interfaced health-monitoring technologies and herald a new era in integrative health technologies., (© 2024 Wiley‐VCH GmbH.)

Background: To evaluate the impact of prostate-specific antigen (PSA) nadir, PSA response and time to PSA nadir (TTN) in metastatic hormone-sensitive prostate cancer (mHSPC) patients on overall survival (OS) in the era of combination therapies., Methods: Different PSA nadir cut-offs (including ultra-low PSA) were tested for OS analyses. Additionally, PSA response ≥99% was evaluated, as well as TTN categorized as <3 versus 3-6 versus 6-12 versus >12 months. Multivariable Cox regression models predicted the value of PSA nadir cut-offs, PSA response and TTN on OS. Sensitivity analyses were performed in de novo and high volume mHSPC patients., Results: Of 238 eligible patients, PSA cut-offs of <0.2 versus 0.2-4.0 versus >4.0 ng/mL differed significantly regarding median OS (96 vs. 56 vs. 44 months, p < 0.01), as well as in subgroup analyses of de novo mHSPC patients and multivariable Cox regression models. A more stringent PSA cut-off of <0.02 versus 0.02-0.2 versus >0.2 ng/mL also yielded significant median OS differences (not reached vs. 96 vs. 50 months, p < 0.01), even after additional multivariable adjustment. A PSA response ≥99% was also significantly associated with better OS than counterparty with <99% response, even after multivariable adjustment (both p < 0.02). When TTN groups were compared, patients with longer TTN harbored more extended OS than those with short TTN (<3 vs. 3-6 vs. 6-12 vs. >12 months: 34 vs. 50 vs. 67 vs. 96 months, p < 0.01). Virtually similar results were observed in sensitivity analyses for high volume mHSPC patients., Conclusions: In times of combination therapies for mHSPC, a PSA nadir of respectively, <0.2 and <0.02 ng/mL are associated with best OS rates. Moreover, a relative PSA response ≥99% and a longer TTN are clinical important proxies for favorable OS estimates., (© 2024 The Author(s). The Prostate published by Wiley Periodicals LLC.)